Author: Nicholas Alan Clayton

Everest Consolidator (MNTN) to Combine with Unifund Financial Technologies in $238M Deal

Everest Consolidator Acquisition Corp. (NYSE:MNTN) has entered into a definitive agreement to combine with consumer debt servicer Unifund at an enterprise value of $238 million, or 4.5x its 2022 revenue.

Cincinnati-based Unifund acquires consumer debts from lenders and provides users means of paying them off over time. ...READ MORE

proxy vote

Minority Equality Opportunities Acquisition Inc. (MEOA) Pushes Extension Vote to May 23

Minority Equality Opportunities (NASDAQ:MEOA) announced this morning that it is postponing its special shareholder meeting from 10 am ET this morning to 2 pm ET tomorrow, May 23.

Shareholders at the meeting are to consider a proposal allowing the SPAC to extend its deadline three months from May 30 to August 30 in exchange for a $250,000 contribution to its trust. ...READ MORE

Fintech Ecosystem Development Corp. (FEXD) Terminates Combination with Rana Financial

Fintech Ecosystem (NASDAQ:FEXD) announced in an 8-K this morning that it has terminated its business combination with financial services provider Rana.

The filing noted that the deal was terminated well before its September 12 outside date because Rana failed to provide audited financial statements to the other parties in a timely manner. ...READ MORE

proxy vote
proxy vote
proxy vote
proxy vote

Corner Growth Acquisition Corp. (COOL) to Combine with Noventiq in $800M Deal

Corner Growth Acquisition Corp. (NASDAQ:COOL) has entered into a definitive agreement to combine with software firm Noventiq (LSE:NVIQ) at an enterprise value of $800 million, or 0.4x its FY2021 revenue.

The London-based company helps companies lead internal digital transformations to drive efficiencies in their IT, cloud storage and cybersecurity systems. ...READ MORE

OceanTech Acquisitions I Corp. (OTEC) to Combine with Regentis Biomaterials in $95M Deal

OceanTech I (NASDAQA:OTEC) has entered into a definitive agreement to combine with regenerative medicine company Regentis at a $95 million valuation.

Or-Akiva, Israel-based Regentis has been working to commercialize its GelrinC orthopedic therapy to repair cartilage damage in knees and has already received a CE mark in Europe as a medical device. ...READ MORE

Compute Health Acquisition Corp. (CPUH) Tweaks Allurion Deal

Compute Health (NYSE:CPUH) announced in an 8-K this morning that it has made a number of amendments to its business combination with Allurion, shifting its financing arrangements.

The bulk of the new financing changes affect the $16.75 million in convertible bridge notes that Allurion issued in February with Hunter Ventures Limited taking on $13 million of these. ...READ MORE